Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line Helicobacter pylori Eradication Therapy

Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line Helicobacter pylori Eradication Therapy

Background /Aims: Both bismuth-containing quadruple therapy and moxifloxacin-containing triple therapy have been suggested as second-line eradication therapy for Helicobacter pylori (H. pylori) infection. We aimed to evaluate the efficacy of 14-day moxifloxacin-containing triple therapy (14-EAM) in...

Full description

Bibliographic Details
Main Authors: Sung Eun Kim, Ji Hun Roh, Moo In Park, Seun Ja Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Jae Joon Heo
Format: Article
Language:English
Published: Jin Publishing & Printing Co. 2019-01-01
Series:The Korean Journal of Gastroenterology
Subjects:
Helicobacter pylori
Disease eradication
Bismuth tripotassium dicitrate
Moxifloxacin
Online Access:http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2019.73.1.26

Internet

http://www.kjg.or.kr/journal/view.html?doi=10.4166/kjg.2019.73.1.26

Similar Items